You are here: Home » 
  1. News


First patient included in the CRUZ-SENIOR STUDY.

The first patient is an important milestone in any clinical trial. In our CRUZ-SENIOR study, Prof. Dr. David M. Leistner and his study team from Charité Universitätsmedizin Berlin succeeded in initiating patient enrolment. The CRUZ-SENIOR study focuses on the treatment of the complex, steadily growing cohort of octogenarian and ninety-year-old patients who have been treated with a Supraflex Cruz stent. This represents one of the most complex high-risk patient cohorts for percutaneous coronary intervention in daily clinical practice. The IHF GmbH team wishes the first and all following patients a fast recovery and good health with a high quality of life.




We would like to get to know you and your ideas.

Start project

Consent to the use of cookies

In order to make our website more appealing to visitors and to enable the use of certain functions, we use cookies on various pages. By continuing to use the website, you consent to the use of cookies. Find out more.

I agree
Scroll to top